Cineverse Reports Q2 Revenue of $12.4 Million with 58% Operating Margin

Reuters
11/15
<a href="https://laohu8.com/S/CNVS">Cineverse</a> Reports <a href="https://laohu8.com/S/QTWO">Q2</a> Revenue of $12.4 Million with 58% Operating Margin

Cineverse Corp. announced its financial results for the second quarter of fiscal year 2026, reporting total revenue of $12.4 million. The company's total revenue declined 3% year-over-year, mainly due to timing differences in revenue recognition for certain content licensing agreements. In the prior-year quarter, $1.6 million was recorded from a Dog Whisperer licensing agreement, while the current quarter includes a $1.1 million licensing deal for The Toxic Avenger Unrated, which will be recognized in future periods. The direct operating margin increased to 58%, a 7 percentage point improvement over the prior-year quarter. Adjusted EBITDA and net income were impacted by planned investments in Cineverse's wide-release film business and Technology group. The company also noted ongoing cost efficiencies from its Cineverse Services India operations. Cineverse highlighted continued growth in its Matchpoint™ platform, which added over 20 new customers in the last 100 days and entered a pilot program with a major Hollywood studio.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cineverse Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA25312) on November 14, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10